AsedaSciences®, founded in 2012 and based in Switzerland, is at the forefront of biotechnology innovation with a mission encapsulated in their slogan: "Helping scientists develop safer chemicals."
Through its revolutionary platform, 3RnD®, AsedaSciences® uses a cloud-based SaaS model incorporating machine learning, validated human-cell–based testing, and dynamic data visualization to advance safety and sustainability in chemical design. By utilizing proprietary models trained on high-quality datasets, the company offers more accurate and ethical toxicity insights earlier in the R&D process.
This unique approach supports the global 3Rs initiatives focused on reducing animal testing, impacting sectors such as pharmaceutical, cosmetics, industrial, and agricultural. The platform accelerates discovery, reduces development costs, and fortifies safety outcomes, empowering industries to innovate with enhanced responsibility and minimal environmental impact.
Despite its significant contributions, AsedaSciences® has yet to receive its last investment, presenting a strong opportunity for investors keen on supporting predictive, human-centric toxicology in the Biotechnology and Life Sciences industries.